Chronic Low Back Pain Clinical Trial
Official title:
Retrospective Study on Safety of Acupuncture Treatments for Chronic Low Back Pain in 65 Years and Older in an Acupuncture Clinic From 2013 to 2018.
Verified date | February 2019 |
Source | McLean Center for Complementary and Alternative Medicine, PLC |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Observational |
Acupuncture, along with other complementary and integrative treatments, is commonly used as a complementary or integrative therapy when treating a multitude of pain complaints, including chronic low back pain(CLBP). It has been practiced as a non-pharmacological therapy in the United States over one hundred years. Integrative pain management pilot programs have demonstrated impressive reductions in medications use, emergency room visits, and annual costs of healthcare. In fact, CLBP is one of the most common conditions treated in an acupuncturist's daily schedule. Based on acupuncturists' practice, CLBP has accounted for about 12% of patient visits in recent years. Most CLBP patients who come to acupuncturists' clinic are older adults. Investigators will retrospectively check the safety of acupuncture, i.e.side effects or adverse effects of acupuncture during treatments of CLBP in older adults in past 5 years.
Status | Completed |
Enrollment | 500 |
Est. completion date | February 20, 2019 |
Est. primary completion date | December 30, 2018 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 65 Years and older |
Eligibility |
Inclusion Criteria: - Age: 65-80 years old. - CLBP is defined as a back pain problem that has persisted for at least 3 months or has resulted in pain on at least half the days in the past 6 months. - A minimum pain intensity score of 4 out of 10 on a visual analog scale (0 = no pain, 10 = most severe pain); - ability of the participant to fully understand the trial procedure and the risks involved, communicate with the examiner, and comply with the protocol; - provision of written informed consent for participation. Exclusion Criteria: - Age: younger than 65. - Pain mainly at legs; - a history of spinal surgery; - hip osteoarthritis; progressive neurological deficit or severe psychiatric or psychological disorders; - serious spinal disorders, such as metastatic cancer, vertebral fracture, spinal infection, and inflammatory spondylitis; - other contraindications for treatment, such as clotting disorders, use of anticoagulants or chemotherapy medications, and seizure disorders; - presence of a device that could be affected by electromagnetic fields, such as a pacemaker; - use of medications that could affect the trial results, such as corticosteroids and anticonvulsants, within the last week; - participation in other clinical trials; - ineligibility judged by a researcher. |
Country | Name | City | State |
---|---|---|---|
United States | McLean Center for Complementary and Alternative Medicine,PLC | Vienna | Virginia |
Lead Sponsor | Collaborator |
---|---|
McLean Center for Complementary and Alternative Medicine, PLC |
United States,
Chan MWC, Wu XY, Wu JCY, Wong SYS, Chung VCH. Safety of Acupuncture: Overview of Systematic Reviews. Sci Rep. 2017 Jun 13;7(1):3369. doi: 10.1038/s41598-017-03272-0. — View Citation
Fan AY, Ouyang H, Qian X, Wei H, Wang DD, He D, Tian H, Gong C, Matecki A, Alemi SF. Discussions on real-world acupuncture treatments for chronic low-back pain in older adults. J Integr Med. 2019 Jan 26. pii: S2095-4964(19)30005-6. doi: 10.1016/j.joim.201 — View Citation
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | The rate of participates with bleeding | bruise in 3 levels: diameter<5mm, 6-10mm, >11mm | 2013-2018 | |
Secondary | The rate of participates with pain | 3 levels: slight(2013-2018 |
| |
Secondary | The rate of participates with fainting | 3 levels: light-headed, slight faint, fainted. | 2013-2018 | |
Secondary | The rate of participates with organ injury | Any organ injury-lung, heart, brain, liver, kidney, etc. | 2013-2018 | |
Secondary | The rate of participates caused Infection | any infection related to acupuncture | 2013-2018 |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03243084 -
Transcranial Alternating Current Stimulation in Back Pain- Pilot Sudy
|
N/A | |
Suspended |
NCT04735185 -
Stem Cells vs. Steroids for Discogenic Back Pain
|
N/A | |
Completed |
NCT03162952 -
RAND Center of Excellence for the Study of Appropriateness of Care in CAM
|
||
Completed |
NCT03240146 -
Pulsed Shortwave Therapy Treatment for Chronic Musculoskeletal Low Back Pain
|
N/A | |
Completed |
NCT05282589 -
Lumbopelvic Manipulation Effects on Fatigue in Chronic Low Back Pain Patients
|
N/A | |
Completed |
NCT03637998 -
Physical Activity on Neurophysiologic Gene Expression Profiles of Chronic Low Back Pain
|
N/A | |
Recruiting |
NCT02289170 -
Clinical Study to Evaluate the Safety and Efficacy of Heating and Cooling Combination Therapeutic Device(OCH-S100)
|
N/A | |
Active, not recruiting |
NCT01944163 -
The IMPACT of a Referral Model for Axial Spondyloarthritis in Young Patients With Chronic Low Back Pain
|
N/A | |
Completed |
NCT02231554 -
Feldenkrais vs Back School for Treating Chronic Low Back Pain: a Randomized Controlled Trial
|
N/A | |
Recruiting |
NCT02063503 -
Identification of Prognostic Indicators for Rehabilitation in Chronic Nonspecific Low Back Pain Patients
|
N/A | |
Completed |
NCT01704677 -
Lumbar Disc Prosthesis Versus Multidisciplinary Rehabilitation; 8-year Follow-up
|
N/A | |
Terminated |
NCT01620775 -
MR(Magnetic Resonance) Imaging of Neurotransmitters in Chronic Pain
|
N/A | |
Completed |
NCT01177241 -
Cytochrome P450 Pharmacokinetic DDIs Among Patients With Chronic Low Back Pain Taking Opioids
|
N/A | |
Completed |
NCT01177254 -
Exposure to Potential Cytochrome P450 Pharmacokinetic Drug-Drug Interactions Among Osteoarthritis Patients: Incremental Risk of Multiple Prescriptions
|
N/A | |
Completed |
NCT01177280 -
Prevalence of Potential Cytochrome P450 Pharmacokinetic Incident Drug-Drug Interactions Among Chronic Low Back Pain Patients Taking Opioid Analgesics and Associated Economic Outcomes
|
N/A | |
Completed |
NCT01490905 -
A Double Blind Placebo Study to Determine the Effectiveness of Theramine on the Management of Chronic Back Pain
|
Phase 4 | |
Completed |
NCT00984815 -
Safety Study of HZT-501 in Patients Who Require Long-Term Daily Non-steroidal Anti-inflammatory Drug Treatment
|
Phase 3 | |
Completed |
NCT00761150 -
Study to Evaluate the Safety and Efficacy of ABT-712 in Subjects With Moderate to Severe Chronic Low Back Pain (CLBP)
|
Phase 3 | |
Completed |
NCT00767806 -
A Study for Patient With Chronic Low Back Pain
|
Phase 3 | |
Completed |
NCT00763321 -
Study to Evaluate the Safety and Efficacy of ABT-712 in Subjects With Moderate to Severe Chronic Low Back Pain (CLBP)
|
Phase 3 |